Literature DB >> 2501782

Multiple enhancer-like sequences in the HLA-B7 gene.

S Ganguly1, H A Vasavada, S M Weissman.   

Abstract

Enhancer-like sequences have previously been identified in the promoter region of the mouse major histocompatibility complex (MHC) class I genes. We have screened for such sequences in and around a human MHC class I gene, HLA-B7. Various restriction fragments of the B7 gene were assayed for their ability to enhance transcription of a bacterial chloramphenicol acetyltransferase gene from a simian virus 40 promoter in transiently transfected mouse LTA cells. Our results demonstrate that enhancer activity is located in introns 3 and 5 as well as 5' to the transcription initiation site. RNase protection experiments corroborate the results. Preliminary experiments indicate that B7 enhancers are active in various cell types. The role of these enhancers in B7 gene expression is not known at present. We speculate that the position of the enhancer elements may be related to the occurrence of Hpa II tiny fragment islands.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501782      PMCID: PMC297598          DOI: 10.1073/pnas.86.14.5247

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Interferon-induced transcription of a major histocompatibility class I gene accompanies binding of inducible nuclear factors to the interferon consensus sequence.

Authors:  Y Shirayoshi; P A Burke; E Appella; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

2.  Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma.

Authors:  P Herbomel; B Bourachot; M Yaniv
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

3.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

4.  A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene.

Authors:  S D Gillies; S L Morrison; V T Oi; S Tonegawa
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

5.  A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes.

Authors:  J Banerji; L Olson; W Schaffner
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

6.  Transcripts of human HLA gene fragments lacking the 5'-terminal region in transfected mouse cells.

Authors:  O Yoshie; H Schmidt; P Lengyel; E S Reddy; W R Morgan; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

7.  Identification of two distinct regulatory regions adjacent to the human beta-interferon gene.

Authors:  K Zinn; D DiMaio; T Maniatis
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

8.  Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate.

Authors:  C M Gorman; B H Howard; R Reeves
Journal:  Nucleic Acids Res       Date:  1983-11-11       Impact factor: 16.971

9.  Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.

Authors:  C V Hall; P E Jacob; G M Ringold; F Lee
Journal:  J Mol Appl Genet       Date:  1983

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  10 in total

1.  Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues.

Authors:  A Dey; A M Thornton; M Lonergan; S M Weissman; J W Chamberlain; K Ozato
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

2.  Differential regulation of HLA class I genes by interferon.

Authors:  H Schmidt; V Gekeler; H Haas; G Engler-Blum; I Steiert; H Probst; C A Müller
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  Identification of cis sequences controlling efficient position-independent tissue-specific expression of human major histocompatibility complex class I genes in transgenic mice.

Authors:  J W Chamberlain; H A Vasavada; S Ganguly; S M Weissman
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

4.  DNase I-hypersensitive sites and transcription factor-binding motifs within the mouse E beta meiotic recombination hot spot.

Authors:  R Shenkar; M H Shen; N Arnheim
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

5.  Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.

Authors:  L T Peltenburg; P I Schrier
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  Transcription analysis, physical mapping, and molecular characterization of a nonclassical human leukocyte antigen class I gene.

Authors:  M J Chorney; I Sawada; G A Gillespie; R Srivastava; J Pan; S M Weissman
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

7.  Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.

Authors:  L T Peltenburg; R Dee; P I Schrier
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

8.  HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons.

Authors:  D R Johnson; J S Pober
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

9.  A novel downstream regulatory element of the mouse H-2Kb class I major histocompatibility gene.

Authors:  J Králová; P Jansa; J Forejt
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

10.  Downregulation of MHC class I expression due to interference with p105-NF kappa B1 processing by Ad12E1A.

Authors:  G J Schouten; A J van der Eb; A Zantema
Journal:  EMBO J       Date:  1995-04-03       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.